僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Ravulizumab （ALXN1210） is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis